EU Refines Simultaneous Scientific Advice Pilot With Focus On Clinical Trials
Executive Summary
Improvements have been made to the second phase of an EU pilot that allows drug sponsors to obtain simultaneous scientific advice from two member states.
You may also be interested in...
EU Aims To Drive Uptake In Decentralized Clinical Trials With Harmonized Guide
The highly anticipated pan-EU recommendation paper on decentralized clinical trials explains the factors that sponsors should consider when designing and implementing such trials.
‘Open & Constructive’: Early Feedback Supports Simultaneous Scientific Advice In Europe
A European pilot project that lets drug companies developing innovative products receive scientific advice from two EU member states at the same time is proving its worth during the pandemic.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.